Financial Results
Aprameya Engineering Announces H1 FY27 Results
Aprameya Engineering approved unaudited standalone and consolidated financial results for the half year ended September 30, 2026, along with limited review reports.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q4 FY25
Bearish
3
Neutral
6
Bullish
5
Bearish
22
Neutral
6
Bullish
18
Bearish
19
Neutral
0
Bullish
13
View Standalone
View Standalone
Bearish
19
Neutral
0
Bullish
13
Bearish
19
Neutral
0
Bullish
13
Bearish
19
Neutral
0
Bullish
13
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Healthcare Equipment & Supplies
Medical Equipment & Supplies
243 Cr
High Risk
-592.6
60.5
-0.1
3.5
360.00
75.00
Sales CAGR
Profit CAGR
ROE
ROCE
Aprameya Engineering Ltd (APRAMEYA) is currently trading at 121.40 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Aprameya Engineering Limited specializes in delivering turnkey projects for hospital infrastructure, including ICUs and Modular Operation Theatres. With strong expertise in healthcare solutions, the company is now diversifying into medical device manufacturing through its subsidiary, Aprameya Medtech Private Limited, marking a strategic expansion. Anticipated 20-25% CAGR over the next three years underlines their high growth trajectory. Targeting Rs 300-350 crore order book, supported by a substantial bid pipeline, is expected to transform its market position significantly. Focused on import substitution, it aims to ramp up production of surgical and specialty equipment.
Over the past 52 weeks, Aprameya Engineering Ltd has traded between a low of ₹75.00 and a high of ₹360.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Aprameya Engineering Ltd has a market capitalization of approximately 242.95. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Aprameya Engineering Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -592.56 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 242.95 Cr, Aprameya Engineering Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Aprameya Engineering Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Aprameya Engineering Ltd is -592.56. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Aprameya Engineering generated Rs 26.21 crore of net operating cash in the half year ended September 30, 2026, against profit before tax of Rs 1.60 crore. Its cash-flow statement shows a Rs 35.02 crore decrease in trade receivables, partly offset by a Rs 4.57 crore inventory increase and a Rs 1.07 crore decrease in trade payables.
Aprameya Engineering reported revenue from operations of Rs 17.1253 crore for the half year ended September 30, 2026, versus Rs 42.1398 crore a year earlier. The filing does not provide management commentary explaining the decline. Its disclosed business is the supply of medical equipment and related service contracts.
Aprameya Engineering reported consolidated revenue from operations of ₹17.13 crore for H1 FY27 ended 30 September 2026. This was 59.4% lower than ₹42.14 crore reported in H1 FY26.